Impact of cigarette smoking on maximal expiratory flows in a general population: The Takahata study

Internal Medicine

Volumn 50, Issue 21, 2011, Pages 2547-2555

  Nemoto, Takako ^a   Shibata, Yoko ^a   Osaka, Daisuke ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Tokairin, Yoshikane ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Kimura, Tomomi ^a   Kishi, Hiroyuki ^a   Nishiwaki, Michiko ^a   Aida, Yasuko ^a   Nunomiya, Keiko ^a   Sato, Masamichi ^a   Watanabe, Tetsu ^a   Konta, Tsuneo ^a   Kawata, Sumio ^a   Kato, Takeo ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cigarette smoking; Community based health check; Maximal expiratory flow; Small airway injury; Spirometry

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL EVALUATION; COMMUNITY ASSESSMENT; CONTROLLED STUDY; FEMALE; FORCED VITAL CAPACITY; HUMAN; JAPAN; MALE; MAXIMAL EXPIRATORY FLOW; SEX DIFFERENCE; SMALL AIRWAY DISEASE; SMOKING HABIT; SPIROMETRY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; MALE; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; POPULATION SURVEILLANCE; QUESTIONNAIRES; SMOKING;

EID: 80455129372     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5948     Document Type: Article

References (26)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620, 2004.
2. Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 175: 1222-1232, 2007.
3. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 9: 458-465, 2004.
4. Ministry of Health Labour and Welfare. Measures for National Health Promotion. Available at http://www.mhlw.go.jp/english/wp/wp-hw2/part2/p3_0024.pdf.
5. World Health Organization Regional Office for Western Paciffic. Available at http://www.wpro.who.int/media_centre/fact_sheets/fs_20020528.htm
6. Pierce R. Spirometry: an essential clinical measurement. Aust Fam Physician 34: 535-539, 2005.
7. Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 125: 110-118, 1976.
8. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 22: 95-108, 1967.
9. Pride NB, Permutt S, Riley RL, Bromberger-Barnea B. Determinants of maximal expiratory flow from the lungs. J Appl Physiol 23: 646-662, 1967.
10. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flowa unifying concept. J Appl Physiol 43: 498-515, 1977.
11. Elliott EA, Dawson SV. Test of wave-speed theory of flow limitation in elastic tubes. J Appl Physiol 43: 516-522, 1977.
12. Prieto F, English MJ, Cochrane GM, Clark TJ, Rigden BG. Spirometry in healthy men: a correlation with smoking and with mild symptoms. Thorax 33: 322-327, 1978.
13. Zhicheng S. A study of lung function in coalworkers' pneumoconiosis. Br J Ind Med 43: 644-645, 1986.
14. Takishima T, Sasaki T, Takahashi K, Sasaki H, Nakamura T. Direct-writing recorder of the flow-volume curve and its clinical application. Chest 61: 262-266, 1972.
15. Sakamoto O, Saita N, Ando M, Kohrogi H, Suga M. Two cases of Sjögren's syndrome with multiple bullae. Intern Med 41: 124-128, 2002.
16. The Committee of Pulmonary Physiology JRSThe Clinical Respiratory Function Test 7th Edition: Forced expiratory curve, flowvolume curve and peak flow. Tokyo: Medical Review 2008 (in Japanese).
17. Osaka D, Shibata Y, Abe S, et al. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata Study. Intern Med 49: 1489-1499, 2010.
18. Konta T, Emi M, Toriyama S, et al. Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the nondiabetic Japanese general population: the Takahata study. J Hum Genet 53: 267-274, 2008.
19. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 70: 751-756, 2006.
20. The Committee of Pulmonary Physiology JRS. Guidelines for Pulmonary Function Tests: Spirometry, flow-volume curve, diffusion capacity of the lung. Tokyo 2004 (in Japanese).
21. 6 in Japanese participants of the community-based annual health check: the Takahata Study. Intern Med 50: 87-93, 2011.
22. Japanese Respiratory Society. http://www.jrs.or.jp/quicklink/glsm/guideline/nopass_pdf/spirogram.pdf.
23. Babb TG, Rodarte JR. Mechanism of reduced maximal expiratory flow with aging. J Appl Physiol 89: 505-511, 2000.
24. O'Donnell D, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Review 15: 61-67, 2006.
25. Battaglia S, den Hertog H, Timmers MC, et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax 60: 639-644, 2005.
26. Kanda S, Fujimoto K, Komatsu Y, Yasuo M, Hanaoka M, Kubo K. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med 49: 23-30, 2010.